Idarubicin, Cytarabine and Pravastatin as Induction Therapy for Untreated Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome
Blood - United States
doi 10.1182/blood.v124.21.3732.3732
Full Text
Open PDFAbstract
Available in full text
Date
December 6, 2014
Authors
Publisher
American Society of Hematology